4
Changes in Ownership
FATE THERAPEUTICS INC Filed Acc 0001193125-26-447171
Chief Financial Officer sold 6,582 shares at $2.05 ($13,525)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Adawi Kamal Chief Financial Officer | 2026-11-03 | Sale | −6,582 | $2.05 | $13,525 | 93,418 | D |
| Open-market sales · 6,582 sh · avg $2.05 · $13,525 | |||||||
Loading xslF345X06/ownership.xml…